www.esmogastro.org/article/S2949-8198(24)00027-X/pdf

Matsubara Y, Bando H, Kotani D, Kagawa Y, Harada K, Osumi H, et al. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer. ESMO Gastrointestinal Oncology. 2024 Jun 1;4:100066.
https://www.esmogastro.org/article/S2949-8198(24)00027-X/pdf

Copyright © National Cancer Center All Rights Reserved.